跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,961 条关于
“Rectify Pharmaceuticals”
全部
8,961
临床试验
593
药物
1,723
机构
2,043
资讯
4,602
21天前
Rectify Pharmaceuticals Unveils RTY-406, an Oral Dual ABCB4/BSEP Modulator for Primary Sclerosing Cholangitis
3个月前
Rectify Pharmaceuticals Reports Promising Preclinical Data for RTY-406 in Primary Sclerosing Cholangitis at EASL 2026
去年
Rectify Pharma's Novel Dual-Targeted PFM Shows Promise for Hepatobiliary Diseases at EASL 2025
去年
Sol-Gel Technologies Receives Nasdaq Extension to Regain Compliance
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
去年
IO Biotech Faces Nasdaq Delisting Risk Despite Promising Cancer Vaccine Advances
去年
MIRA Pharmaceuticals to Acquire SKNY Pharmaceuticals, Expanding into $200 Billion Weight Loss and Smoking Cessation Markets
去年
ARIAD Pharmaceuticals Accelerates Ponatinib to Market
去年
OnKure Therapeutics Advances Mutant-Specific PI3Kα Inhibitor OKI-219 Following Merger
第 1 页,共 461 页
上一页
下一页